Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - levonorgestrel, quantity: 0.15 mg; ethinylestradiol, quantity: 0.03 mg - tablet, sugar coated - excipient ingredients: erythrosine; maize starch; glycol montanate; sucrose; brilliant scarlet 4r; macrogol 6000; lactose monohydrate; purified talc; povidone; magnesium stearate; calcium carbonate - nordette is indicated for the prevention of pregnancy.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - levonorgestrel, quantity: 0.15 mg; ethinylestradiol, quantity: 0.03 mg - tablet, sugar coated - excipient ingredients: povidone; lactose monohydrate; magnesium stearate; erythrosine; sucrose; purified talc; macrogol 6000; calcium carbonate; maize starch; brilliant scarlet 4r; glycol montanate - indicated for the prevention of pregnancy.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinylestradiol, quantity: 20 microgram; levonorgestrel, quantity: 100 microgram - tablet, film coated - excipient ingredients: lactose monohydrate; macrogol 1500; magnesium stearate; microcrystalline cellulose; glycol montanate; polacrilin potassium; titanium dioxide; hypromellose; hyprolose; macrogol 400 - 1. the prevention of pregnancy. 2. the treatment of moderate acne vulgaris not controlled with topical preparations in post-menarchal, pre-menopausal women who accept contraception.

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - primidone - oral tablet - 50mg

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

serb - primidone - oral tablet - 50mg

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - primidone - oral tablet - 50mg

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme australia pty ltd - oestriol -

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme australia pty ltd - oestriol -

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme australia pty ltd - oestriol -

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - estriol, quantity: 1 mg/g - cream - excipient ingredients: sodium hydroxide; stearyl alcohol; lactic acid; cetyl esters wax; purified water; chlorhexidine hydrochloride; sorbitan monostearate; octyldodecanol; glycerol; polysorbate 60; cetyl alcohol - indications as at 18 december 2001. vulvo-vaginal complaints due to oestrogen deficiency associated with the climacteric and the postmenopause or after ovariectomy: atrophic vaginitis. puritis vulvae. dyspareunia due to vulvo-vaginal atrophy. as auxiliary therapy in the treatment of vaginal infections. as pre-operative therapy for vulvo-vaginal surgery and during subsequent convalescence. ulcers in the case of prolapse of the uterus or vagina. to avoid misinterpretation of a cytological smear.